Search

everythinglearnresearchcommunity

for

Search:↓

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

RCS-01 therapy is safe and may improve skin structure by affecting gene expression.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

The new clobetasol propionate foam is effective and safe for treating alopecia areata.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

AGA is a common hair loss affecting both genders, treated with various therapies to promote regrowth and slow thinning.

Plant extracts like Avicennia marina, Boehmeria nipononivea, and Camellia sinensis could potentially treat hair loss with fewer side effects than synthetic drugs.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Some blood thinners can cause hair loss, but switching medications can stop it.

Surgery is the main treatment for liver hydatidosis, but has risks; albendazole is the most effective drug but can have side effects.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Liposomal anthracyclines are effective and safer for treating multiple myeloma, especially in elderly patients.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Six African American women experienced hair loss after switching to a new HIV medication.

JAK inhibitors help hair regrowth in alopecia areata but have a high risk of side effects.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

Men need higher doses of botox than women and a different approach for facial aesthetics due to their unique facial features and muscle mass.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Adding stem cells to fat grafts for facial rejuvenation might improve outcomes, but more research is needed to confirm safety and effectiveness.

Derinat may improve hair growth and quality of life in hair loss patients by reducing oxidative stress.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

FGF-2&D/P nanoparticles can help treat hair loss.